Decosterd L. | Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
スポンサーリンク
概要
- DECOSTERD L. A.の詳細を見る
- 同名の論文著者
- Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier Uの論文著者
関連著者
-
Decosterd L.
Division Of Clinical Pharmacology Department Of Internal Medicine Bh 18-lab 218 Centre Hospitalier U
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
Biollaz J.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
BIOLLAZ J.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
DECOSTERD L.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
Buclin T.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Beguin A.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
BEGUIN A.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
BUCLIN T.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
Rochat B.
Plate-forme De Spectrometrie De Masse Department De Recherche Centre Hospitalier Universitaire Vaudo
-
Leyvraz S.
Pluridisciplinary Cancer Center Centre Hospitalier Universitaire Vaudois
-
Telenti A.
Institute Of Microbiology University Hospital Of Lausanne
-
ZANOLARI B.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
Zanolari B.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Zanolari B.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
Colombo S.
Division De Pharmacologie Clinique Laboratoire Bh 18-218 Department De Medicine Centre Hospitalier U
-
Guignard N.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
Widmer N.
Division De Pharmacologie Clinique Laboratoire Bh 18-218 Department De Medicine Centre Hospitalier U
-
Duchosal M.
Service D'hematologie Department De Medicine Centre Hospitalier Universitaire Vaudois
-
MARZOLINI C.
Division de Pharmacologie clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
TELENTI A.
Virologie Medicale, Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois
-
Marzolini C.
Division De Pharmacologie Clinique Laboratoire Bh 18-218 Department De Medicine Centre Hospitalier U
-
Zaman K.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
Rochat B.
Quantitative Mass Spectrometry Facility Of The Chromatography-mass Spectrometry Platform Of The Univ
-
Leyvraz S.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
CRUCHON S.
Division of Clinical Pharmacology and Toxicology, University Hospital of Lausanne
-
MERCIER T.
Division of Clinical Pharmacology and Toxicology, Department of Medicine, Lausanne, Centre Hospitali
-
Cruchon S.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Mercier T.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Widmer N.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
Olliaro P.
Unicef/undp/wb/who Special Programme For Research And Training In Tropical Diseases (tdr) World Heal
-
ROCHAT B.
Plate-forme de Spectrometrie de Masse, Department de Recherche, Centre Hospitalier Universitaire Vau
-
KOVACSOVICS T.
Service d'Hematologie, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
DUCHOSAL M.
Service d'Hematologie, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
LEYVRAZ S.
Centre coordonne d'Oncologie Ambulatoire, Centre Hospitalier Universitaire Vaudois
-
ROSSELET A.
Service d'Hematologie, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
Pascual M.
Centre De Transplantation D'organes Centre Hospitalier Universitaire Vaudois
-
Rosselet A.
Service D'hematologie Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Kovacsovics T.
Service D'hematologie Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Karagiannis A.
Division D'hypertension Department De Medicine Centre Hospitalier Universitaire Vaudois
-
TELENTI A.
Medical Virology, Institute of Microbiology, University Hospital of Lausanne
-
ROCHAT B.
Mass Spectrometry Unit of the Research Department, University Hospital of Lausanne
-
PERROTTET N.
Division de Pharmacologie Clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
MEYLAN P.
Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois
-
MANUEL O.
Centre de Transplantation d'Organes, Centre Hospitalier Universitaire Vaudois
-
GUIGNARD N.
Division de Pharmacologie clinique, Department de Medicine, Laboratoire BH 18-218, Centre Hospitalie
-
ROULET J.-M.
Institut de Chimie Organique, Faculte des Sciences, Universite de Lausanne
-
BELAZ N.
Division de Pharmacologie Clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
APPENZELLER M.
Division de Pharmacologie Clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
VOGEL P.
Institut de Chimie Organique, Faculte des Sciences, Universite de Lausanne
-
SHEN F.
Division of Clinical Pharmacology, Department of Internal Medicine, BH 18-Lab 218, Centre Hospitalie
-
GANDER M.
Pluridisciplinary Cancer Center, Centre Hospitalier Universitaire Vaudois
-
LEJEUNE F.
Pluridisciplinary Cancer Center, Centre Hospitalier Universitaire Vaudois
-
Meylan P.
Institut De Microbiologie Centre Hospitalier Universitaire Vaudois
-
Perrottet N.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Belaz N.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois 1
-
Gander M.
Pluridisciplinary Cancer Center Centre Hospitalier Universitaire Vaudois
-
Lejeune F.
Pluridisciplinary Cancer Center Centre Hospitalier Universitaire Vaudois
-
Roulet J.-m.
Institut De Chimie Organique Faculte Des Sciences Universite De Lausanne
-
HAOUALA A.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
MONTEMURRO M.
Multidisciplinary Oncology Centre, Centre Hospitalier Universitaire Vaudois and University of Lausan
-
RIS H.
Divisions of Thoracic and Vascular Surgery, Centre Hospitalier Universitaire Vaudois and University
-
FAYET A.
Division of Clinical Pharmacology and Toxicology, University Hospital of Lausanne
-
CAVASSINI M.
Service of Infectious Diseases, University Hospital of Lausanne
-
GUNTHARD H.
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich
-
Ris H.
Divisions Of Thoracic And Vascular Surgery Centre Hospitalier Universitaire Vaudois And University O
-
Haouala A.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
Montemurro M.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
DAHMANE E.
Division of Clinical Pharmacology and Toxicology, Department of Medicine, Lausanne, Centre Hospitali
-
CSAJKA C.
Division of Clinical Pharmacology and Toxicology, Department of Medicine, Lausanne, Centre Hospitali
-
HODEL E.
Swiss Tropical Institute
-
KEISER J.
Swiss Tropical Institute
-
GENTON B.
Swiss Tropical Institute
-
Cavassini M.
Service Of Infectious Diseases University Hospital Of Lausanne
-
Fayet A.
Division Of Clinical Pharmacology And Toxicology University Hospital Of Lausanne
-
Gunthard H.
Division Of Infectious Diseases And Hospital Epidemiology University Hospital Zurich
-
Csajka C.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Dahmane E.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Appenzeller M.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois 1
-
Olliaro P.
Unicef/undp/world Bank/who Special Programme For Research And Training In Tropical Diseases (tdr)
-
Vogel P.
Institut De Chimie Organique Faculte Des Sciences Universite De Lausanne
-
Manuel O.
Centre De Transplantation D'organes Centre Hospitalier Universitaire Vaudois
-
Shen F.
Division Of Clinical Pharmacology Department Of Internal Medicine Bh 18-lab 218 Centre Hospitalier U
-
Biollaz J.
Division Of Clinical Pharmacology Department De Medicine University Hospital And University Of Lausanne
-
DECOSTERD L.
Division of Clinical Pharmacology, Department de Medicine, University Hospital and University of Lausanne
著作論文
- Determination of imatinib (Gleevec^【○!R】) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection
- Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry
- Determination of aciclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples
- Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction
- Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction
- High-performance liquid chromatography of the renal blood flow marker p-aminohippuric acid (PAH) and its metabolite N-acetyl PAH improves PAH clearance measurements
- Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction
- Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry
- A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents : Raltegravir, maraviroc, darunavir, and etravirine
- An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma : First evidence of 4'-hydroxylated metabolites in breast cancer patients
- A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma